Advertisement

Topics

CureVac AG Company Profile

14:19 EDT 16th October 2018 | BioPortfolio

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the development of cancer therapies, prophylactic vaccines and molecular therapies.


News Articles [7 Associated News Articles listed on BioPortfolio]

CureVac Announces New Management Structure

TÜBINGEN, Germany and BOSTON, May 08, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Founder and ...

Curevac reports another failed cancer vaccine

CureVac inks $1.7bn deal on mRNA cancer vaccines

CureVac Announces Appointment of Matthew L. S. Beck as Vice President of Investor Relations

TÜBINGEN, Germany and BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the appointment o...

Curevac AG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryCurevac AG Curevac, formerly CureVac GmbH is a clinicalstage biopharmaceutical company that develops RNAbased medicines. The company develops, designs, and produces messenger RNA molecules for ...

Curevac AG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

SummaryCurevac AG Curevac, formerly CureVac GmbH is a clinical stage biopharmaceutical company that develops RNAbased medicines. The company designs, develops and produces messenger RNA molecules for ...

Curevac AG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryCurevac AG Curevac, formerly CureVac GmbH is a clinical stage biopharmaceutical company that develops RNAbased medicines. The company designs, develops and produces messenger RNA molecules for ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

CureVac AG

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical...

The International mRNA Health Conference

The International mRNA Health Conference brings together top scientists and professionals from all around the world to discuss the rapidly growing field of mRNA while fostering or...

CureVac GmbH

We are dedicated to offering reliable and innovative RNA related products and services to the Life Science Community. siRNA [order here]: ultrapure (HPLC purified)For the design of siRNA please use EM...

More Information about "CureVac AG" on BioPortfolio

We have published hundreds of CureVac AG news stories on BioPortfolio along with dozens of CureVac AG Clinical Trials and PubMed Articles about CureVac AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CureVac AG Companies in our database. You can also find out about relevant CureVac AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record